These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22321935)

  • 21. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
    Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
    Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
    Saito T; Nishimura M; Yamasaki H; Kudo R
    Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma.
    Meng XY; Zhu ST; Zong Y; Wang YJ; Li P; Zhang ST
    Dis Esophagus; 2011 Aug; 24(6):444-9. PubMed ID: 21166741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
    Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on DNA methylation status of WT1 gene in its promoter region in hematologic malignancy cell lines].
    Zhao Y; Chen ZX; Hu SY; Cen JN; Gu WY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):517-20. PubMed ID: 16468326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
    Ogama Y; Ouchida M; Yoshino T; Ito S; Takimoto H; Shiote Y; Ishimaru F; Harada M; Tanimoto M; Shimizu K
    Int J Oncol; 2004 Sep; 25(3):685-91. PubMed ID: 15289870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b.
    Kwon O; Jeong SJ; Kim SO; He L; Lee HG; Jang KL; Osada H; Jung M; Kim BY; Ahn JS
    Carcinogenesis; 2010 Jul; 31(7):1194-201. PubMed ID: 20375073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
    Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
    Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer].
    Yan WJ; Guo MZ; Yang YS
    Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):390-3. PubMed ID: 22883340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro study of human mutL homolog 1 hypermethylation in inducing drug resistance of esophageal carcinoma.
    Cao Y; Chen Y; Huang Y; Liu Z; Li G
    Ir J Med Sci; 2017 May; 186(2):257-263. PubMed ID: 26782688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [5-aza-2'-deoxycytidine-induced inhibition of CDH13 expression and its inhibitory effect on methylation status in human colon cancer cells in vitro and on growth of xenograft in nude mice].
    Ren JZ; Huo JR
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):6-10. PubMed ID: 22490847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Role of 5-Aza-CdR on Methylation of Promoter in RASSF1A Gene in Endometrial Carcinoma].
    Huang LP; Chen C; Wang XP; Liu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):380-3. PubMed ID: 26121857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.
    Jin Z; Cheng Y; Olaru A; Kan T; Yang J; Paun B; Ito T; Hamilton JP; David S; Agarwal R; Selaru FM; Sato F; Abraham JM; Beer DG; Mori Y; Shimada Y; Meltzer SJ
    Int J Cancer; 2008 Nov; 123(10):2331-6. PubMed ID: 18729198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications.
    Takeno S; Noguchi T; Fumoto S; Kimura Y; Shibata T; Kawahara K
    Am J Clin Pathol; 2004 Jul; 122(1):78-84. PubMed ID: 15272533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas.
    Nakayama S; Sasaki A; Mese H; Alcalde RE; Tsuji T; Matsumura T
    Int J Cancer; 2001 Sep; 93(5):667-73. PubMed ID: 11477576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.